Skip to main content

Neuro degenerazione

Alzheimer’s disease

Definition

Alzheimer’s disease, also known as Alzheimer’s dementia, is a progressive neurodegenerative disease that affects the brain and represents the most common form of dementia. It is named after the psychiatrist Alois Alzheimer, who first described the symptoms and characteristics of the disease in 1906.

Description

Alzheimer’s disease is characterized by the gradual loss of cognitive functions, such as memory, abstract thinking, spatial-temporal orientation, and language skills. Over time, the disease progresses and also affects behavior and the ability to carry out daily activities.

Causes

The exact causes of Alzheimer’s disease are not yet fully understood, but they are believed to be the result of a combination of genetic, environmental, and lifestyle factors. The formation of beta-amyloid protein plaques and tau protein tangles in the brain are considered key characteristics of the disease.

Symptoms

The early symptoms of Alzheimer’s disease may include occasional forgetfulness, difficulties in planning and problem solving, language problems, and mental confusion. As the disease progresses, symptoms become more evident and may include short-term memory loss, difficulty recognizing family members and friends, irritability, anxiety, depression, and difficulty performing daily activities.


  • GUIDED MEDITATIONS

    Three practices to train the mind

    Fill out the form
    and watch the video now

    "*" indicates required fields

    Dati Anagrafici*

Diagnosis

The diagnosis of Alzheimer’s disease is based on the exclusion of other causes of cognitive decline and on the evaluation of symptoms. Various diagnostic procedures are involved, including neuropsychological tests, blood tests, brain imaging such as positron emission tomography (PET) and magnetic resonance imaging (MRI), as well as the exclusion of other conditions.

Treatment

Currently, there is no definitive cure for Alzheimer’s disease. However, some medications may be prescribed to manage symptoms and delay the progression of the disease. Care and support for patients and their families are of fundamental importance in improving the quality of life of people affected by this disease.

Several studies indicate how physical exercise can produce beneficial effects in patients with amnestic mild cognitive impairment (aMCI) and Alzheimer’s disease (AD). It has therefore been suggested to include targeted motor activities both for preventive purposes and in the treatment of the early stages of the disease. For this purpose, so-called “Mindful Movement” practices present themselves as a possible resource of great value currently being investigated by scientific research.

Prognosis

Alzheimer’s disease is a progressive condition that worsens over time. The duration of the disease may vary from person to person, but in general it can extend over several years. During the advanced stages of the disease, severe cognitive and physical difficulties may occur, making full-time assistance necessary.

Research

Research on Alzheimer’s disease is ongoing in order to better understand its causes and develop new therapies. Efforts are aimed at identifying early markers of the disease, developing drugs that can slow its progression, and improving care and assistance strategies for patients and their families.

Alzheimer’s disease represents a significant challenge for public health, as it affects an ever-increasing number of elderly people worldwide. Raising awareness of the importance of early diagnosis, access to appropriate medical support, and adequate assistance are essential to address the complexities associated with this debilitating disease.

Fondazione Patrizio Paoletti is currently involved as the leader of the European project AIDA with the aim of developing a new approach for Alzheimer’s patients, to improve their quality of life and that of their caregivers, their social relationships, the environment in which they live, and the services they receive.

Click here to find out more

Bibliography
  • Babiloni C, De Pandis MF, Vecchio F, Buffo P, Sorpresi F, Frisoni GB, Rossini PM. Cortical sources of resting state electroencephalographic rhythms in Parkinson’s disease related dementia and Alzheimer’s disease. Clin. Neurophysiol. 2011b;122(12):2355-64.
  • Babiloni C, Lizio R, Del Percio C, Marzano N, Soricelli A, Salvatore E, Ferri R, Cosentino FI, Tedeschi G, Montella P, Marino S, De Salvo S, Rodriguez G, Nobili F, Vernieri F, Ursini F, Mundi C, Richardson JC, Frisoni GB, Rossini PM. Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer’s disease. J. Alzheimer’s Dis. 2013;34(4):1015-35.
  • Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011; 10: 819–828.
  • Ben-Soussan T. D., Berkovich-Ohana A., Glicksohn J., and Goldstein A., “A suspended act: increased reflectivity and genderdependent electrophysiological change following Quadrato Motor Training,” Frontiers in Psychology, vol. 5, article 55, 2014.
  • Ben-Soussan T. D., Glicksohn J, Goldstein A, Berkovich-Ohana A, Donchin O. Into the square and out of the box: the effects of Quadrato Motor Training on creativity and alpha coherence. PLoS One. 2013;8(1):e55023. doi: 10.1371/journal.pone.0055023. Epub 2013 Jan 30.
  • Ben-Soussan T.D., Glicksohn J, Berkovich-Ohana A. From Cerebellar Activation and Connectivity to Cognition: A Review of the Quadrato MotorTraining. Biomed. Res. Int. 2015a;2015:954901. doi: 10.1155/2015/954901. Epub 2015 Oct 11. Review
  • Ben-Soussan TD, Berkovich-Ohana A, Piervincenzi C, Glicksohn J, Carducci F. Embodied cognitive flexibility and neuroplasticity following Quadrato Motor Training. Front Psychol. 2015 b;6:1021. doi: 10.3389/fpsyg.2015.01021. eCollection 2015.
  • Blondell SJ, Hammersley-Mather R, Veerman JL. Does physical activity prevent cognitive decline and dementia? A systematic review and meta-analysis of longitudinal studies. BMC Public Health 2014; 14: 510.
  • Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens P, Vellas B, Touchon J; MCI Working Group of the European Consortium on Alzheimer’s Disease (EADC). Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease. J. Neurol. Neurosurg. Psychiatry. 2006 Jun;77(6):714-8. Epub 2006 Mar 20.

Sii parte del cambiamento. Condividere responsabilmente contenuti è un gesto che significa sostenibilità

Alleniamo l'intelligenza emotiva: che emozione ti suscita questo articolo?

Loading spinner

Potrebbe interessarti

Subscribe to the newsletter